Browsing by Yonsei Author : Ahn, Joong Bae

Name:
Ahn, Joong Bae [안중배] http://orcid.org/0000-0001-6787-1503
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
(7403019591)

Keyword Cloud

Researcher Network

Showing results 51 to 100 of 136

This table browses all dspace content
Issue DateTitleJournal Title
2015Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children CANCER RESEARCH AND TREATMENT
2014Exercise barriers in korean colorectal cancer patients ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
2014Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxaneCANCER CHEMOTHERAPY AND PHARMACOLOGY
2014High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients WORLD JOURNAL OF SURGICAL ONCOLOGY
2014Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.JOURNAL OF SURGICAL ONCOLOGY
2014Vascular Soft-Tissue Sarcomas: A Prognostic Model from a Retrospective Single-Center StudyONCOLOGY
2014Can a Biomarker-Based Scoring System Predict Pathologic Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer?DISEASES OF THE COLON & RECTUM
2014Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkersJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2014Differential Expression of CD133 Based on Microsatellite Instability Status in Human Colorectal CancerMOLECULAR CARCINOGENESIS
2013Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort StudyANNALS OF SURGICAL ONCOLOGY
2013Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinomaCANCER CHEMOTHERAPY AND PHARMACOLOGY
2013Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patientsCANCER CHEMOTHERAPY AND PHARMACOLOGY
2013Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medicationsINTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
2013Changing treatment patterns in elderly patients with resectable colon cancerASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2013Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells.ANTICANCER RESEARCH
2013Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors SUPPORTIVE CARE IN CANCER
2013Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2013Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience RADIATION ONCOLOGY JOURNAL
2013Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational StudyJOURNAL OF SURGICAL ONCOLOGY
2013Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agentINVESTIGATIONAL NEW DRUGS
2012Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancerSURGICAL ONCOLOGY-OXFORD
2012A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy.INVESTIGATIONAL NEW DRUGS
2012A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.INVESTIGATIONAL NEW DRUGS
2012Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2012VIPoma that arose from the rectum in a 65-year-old male patient.INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2012Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells. BMC GENOMICS
2012Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience. BMC CANCER
2012Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometryANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
2011DNA methylation predicts recurrence from resected stage III proximal colon cancer CANCER
2011Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasisONCOLOGY
2011Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. RADIATION ONCOLOGY
2011Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancerINVESTIGATIONAL NEW DRUGS
2011Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.ONCOLOGY
2011A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy CANCER
2011Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancerSUPPORTIVE CARE IN CANCER
2011Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis.ONCOLOGY REPORTS
2011Brain metastases from colorectal carcinoma: prognostic factors and outcomeJOURNAL OF NEURO-ONCOLOGY
201118Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer.JOURNAL OF SURGICAL ONCOLOGY
2010The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study RADIATION ONCOLOGY
2010Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites CANCER RESEARCH AND TREATMENT
2010Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial?INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2010A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancerINVESTIGATIONAL NEW DRUGS
2010Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancerRADIOTHERAPY AND ONCOLOGY
2010A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
2010Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2010Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patientsCANCER LETTERS
2009Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction YONSEI MEDICAL JOURNAL
2009Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2009Clinical value of ezrin expression in primary osteosarcoma CANCER RESEARCH AND TREATMENT

Browse

Links